Skip to the page

Data / Form D filings / LENSAR, Inc.

LENSAR, Inc.: Form D filings

LENSAR, Inc., a health care company in Orlando, FL, filed 15 Form D notices with the SEC between 2009 and 2023. The latest, on May 26, 2023, reports $20 million sold of a $20 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2800 Discovery Drive, Suite 100, Orlando, FL, 32826
Phone
(888) 536-7271
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
$25,000,001 - $100,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1320350

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 26, 2023New notice$20,000,000$20,000,0001May 12, 2023sec.gov
Jan 14, 2015Amendment$20,000,000$16,000,000$4,000,0002Jul 14, 2014sec.gov
Nov 12, 2014Amendment$10,000,000$10,000,0002Jul 14, 2014sec.gov
Jul 31, 2014New notice$8,000,000$8,000,0002Jul 14, 2014sec.gov
Jan 9, 2014New notice$10,000,000$10,000,00014Dec 20, 2013sec.gov
Aug 22, 2013New notice$19,780,585$17,440,464$2,340,1213Aug 1, 2013sec.gov
Dec 17, 2012New notice$5,000,000$5,000,0003Nov 29, 2012sec.gov
Mar 16, 2012New notice$24,048,000$24,048,0002Mar 2, 2012sec.gov
Dec 19, 2011New notice$1,425,000$1,425,0001Dec 2, 2011sec.gov
Oct 12, 2011New notice$8,000,000$4,000,000$4,000,0001Oct 5, 2011sec.gov
Sep 1, 2011New notice$6,000,000$5,000,000$1,000,0002Aug 22, 2011sec.gov
Apr 14, 2011New notice$7,000,000$2,000,000$5,000,0002Apr 1, 2011sec.gov
Jul 29, 2010New notice$12,000,000$7,000,000$5,000,0002Jul 16, 2010sec.gov
Aug 19, 2009Amendment$15,805,809$7,096,818$8,708,9913Jul 2, 2009sec.gov
Jul 14, 2009New notice$15,805,809$6,500,000$9,305,8091Jul 2, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gary M. WinerDirector
Richard L. LindstromDirector
Thomas R. Staab, IIExecutive Officer
Aimee S. WeisnerDirector
Alan B. ConnaughtonExecutive Officer
Elizabeth G. O'FarrellDirector
William J. LinkDirector
Nicholas T. CurtisExecutive Officer, Director
John P. McLaughlinDirector

Other health care companies in Florida that filed recently

Every Form D from the week of May 22, 2023 · All recent filings in Florida · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what LENSAR, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.